ZNF121
gene geneOn this page
Also known as ZHC32ZNF20
Summary
ZNF121 (zinc finger protein 121, HGNC:12904) is a protein-coding gene on chromosome 19p13.2, encoding Zinc finger protein 121 (P58317). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 7675 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 97 total
- MANE Select transcript:
NM_001008727
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:12904 |
| Approved symbol | ZNF121 |
| Name | zinc finger protein 121 |
| Location | 19p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | ZHC32, ZNF20 |
| Ensembl gene | ENSG00000197961 |
| Ensembl biotype | protein_coding |
| OMIM | 194628 |
| Entrez | 7675 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000320451, ENST00000586602, ENST00000591447
RefSeq mRNA: 2 — MANE Select: NM_001008727
NM_001008727, NM_001308269
CCDS: CCDS32902, CCDS77228
Canonical transcript exons
ENST00000320451 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001430196 | 9560329 | 9567109 |
| ENSE00001486771 | 9569002 | 9569082 |
| ENSE00001628419 | 9584461 | 9584504 |
| ENSE00003631073 | 9568095 | 9568175 |
Expression profiles
Bgee: expression breadth ubiquitous, 246 present calls, max score 94.61.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 33.8173 / max 832.8301, expressed in 1800 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 179014 | 22.1417 | 1779 |
| 179015 | 11.6757 | 1716 |
Top tissues by expression
247 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| skin of hip | UBERON:0001554 | 94.61 | gold quality |
| gingiva | UBERON:0001828 | 94.48 | gold quality |
| gingival epithelium | UBERON:0001949 | 94.38 | gold quality |
| parietal pleura | UBERON:0002400 | 93.77 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 93.53 | gold quality |
| upper leg skin | UBERON:0004262 | 93.47 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 93.31 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 93.13 | gold quality |
| thymus | UBERON:0002370 | 92.97 | gold quality |
| visceral pleura | UBERON:0002401 | 92.52 | gold quality |
| mammalian vulva | UBERON:0000997 | 92.29 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 92.25 | gold quality |
| oral cavity | UBERON:0000167 | 91.65 | gold quality |
| colonic mucosa | UBERON:0000317 | 91.63 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 91.07 | gold quality |
| mammary duct | UBERON:0001765 | 90.96 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 90.93 | gold quality |
| corpus epididymis | UBERON:0004359 | 90.69 | gold quality |
| seminal vesicle | UBERON:0000998 | 90.65 | gold quality |
| cartilage tissue | UBERON:0002418 | 90.62 | gold quality |
| cauda epididymis | UBERON:0004360 | 90.59 | gold quality |
| caput epididymis | UBERON:0004358 | 90.39 | gold quality |
| amniotic fluid | UBERON:0000173 | 90.30 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 89.88 | gold quality |
| bronchial epithelial cell | CL:0002328 | 89.82 | gold quality |
| bronchus | UBERON:0002185 | 89.52 | gold quality |
| oocyte | CL:0000023 | 89.51 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 89.51 | gold quality |
| penis | UBERON:0000989 | 89.24 | gold quality |
| tibia | UBERON:0000979 | 89.08 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-9801 | yes | 6.53 |
| E-ENAD-17 | no | 907.16 |
| E-GEOD-110499 | no | 648.55 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2582.1 | ZNF121 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:37971293
miRNA regulators (miRDB)
26 targeting ZNF121, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-539-5P | 99.93 | 70.30 | 2855 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-4302 | 99.89 | 67.94 | 1187 |
| HSA-MIR-6857-5P | 99.87 | 65.32 | 985 |
| HSA-MIR-6844 | 99.82 | 70.69 | 2423 |
| HSA-MIR-6515-3P | 99.82 | 68.19 | 1933 |
| HSA-MIR-543 | 99.52 | 69.03 | 2595 |
| HSA-MIR-4452 | 99.50 | 68.45 | 1493 |
| HSA-MIR-6740-3P | 99.48 | 68.49 | 1392 |
| HSA-MIR-642A-3P | 99.23 | 67.67 | 1258 |
| HSA-MIR-642B-3P | 99.23 | 67.67 | 1258 |
| HSA-MIR-4536-5P | 98.47 | 64.39 | 657 |
| HSA-MIR-4450 | 98.26 | 68.35 | 725 |
| HSA-MIR-6783-5P | 97.67 | 67.21 | 1528 |
| HSA-MIR-6824-5P | 97.41 | 68.43 | 583 |
| HSA-MIR-10398-5P | 97.12 | 64.94 | 1051 |
| HSA-MIR-5579-5P | 96.32 | 68.54 | 730 |
| HSA-MIR-584-5P | 95.82 | 68.05 | 848 |
Literature-anchored findings (GeneRIF, showing 2)
- ZNF121 as a MYC-interacting protein with functional effects on MYC and cell proliferation (PMID:27988300)
- Circular RNA hsa_circRNA_103809 promotes lung cancer progression via facilitating ZNF121-dependent MYC expression by sequestering miR-4302. (PMID:29698681)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp560 | ENSMUSG00000045519 |
| rattus_norvegicus | Zfp560 | ENSRNOG00000048394 |
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 121 — P58317 (reviewed: P58317)
Alternative names: Zinc finger protein 20
All UniProt accessions (2): P58317, K7EQI1
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (2): NP_001008727, NP_001295198 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF13465
UniProt features (14 total): zinc finger region 11, sequence conflict 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P58317-F1 | 67.95 | 0.34 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 77 (showing top):
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN, STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN, MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP, CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1, MILI_PSEUDOPODIA_HAPTOTAXIS_UP, ATTCTTT_MIR186, DODD_NASOPHARYNGEAL_CARCINOMA_UP, TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP, BROWNE_HCMV_INFECTION_14HR_UP, ZHENG_BOUND_BY_FOXP3, CHEN_HOXA5_TARGETS_9HR_UP, chr19p13, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, DODD_NASOPHARYNGEAL_CARCINOMA_DN, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
GO Biological Process (1): regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
444 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF121 | SCRN3 | Q0VDG4 | 287 |
| ZNF121 | CCDC82 | Q8N4S0 | 284 |
| ZNF121 | ZNF518A | Q6AHZ1 | 279 |
| ZNF121 | LSG1 | Q9H089 | 273 |
| ZNF121 | TMEM263 | Q8WUH6 | 270 |
| ZNF121 | NDUFV3 | P56181 | 261 |
| ZNF121 | KIAA1549L | Q6ZVL6 | 252 |
| ZNF121 | MITD1 | Q8WV92 | 249 |
| ZNF121 | TNRC18 | O15417 | 249 |
| ZNF121 | FAM76B | Q5HYJ3 | 245 |
| ZNF121 | TM7SF3 | Q9NS93 | 239 |
| ZNF121 | C9JR48 | C9JR48 | 238 |
| ZNF121 | HSDL1 | Q3SXM5 | 234 |
| ZNF121 | MYC | P01106 | 231 |
| ZNF121 | HIPK3 | Q9H422 | 230 |
| ZNF121 | SLC66A1 | Q6ZP29 | 230 |
IntAct
69 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CCAR2 | MYC | psi-mi:“MI:0915”(physical association) | 0.750 |
| NOP53 | RRP8 | psi-mi:“MI:0914”(association) | 0.640 |
| ZNF837 | ZNF121 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF121 | ZNF835 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF121 | TRIM41 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF121 | KRTAP10-8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF121 | RBAK | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF121 | CARD9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF121 | ZNF837 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF121 | KEAP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF169 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF324B | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF512 | ZNF724 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF2 | MPHOSPH10 | psi-mi:“MI:0914”(association) | 0.530 |
| ZBTB48 | ZBTB24 | psi-mi:“MI:0914”(association) | 0.530 |
| RPSA | DKC1 | psi-mi:“MI:0914”(association) | 0.530 |
| MAGEB2 | POLRMT | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF286A | HERC2 | psi-mi:“MI:0914”(association) | 0.530 |
| RPSA | RPS17 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF121 | MYC | psi-mi:“MI:0915”(physical association) | 0.480 |
| MPHOSPH8 | HCFC1 | psi-mi:“MI:0914”(association) | 0.350 |
| MYC | ILVBL | psi-mi:“MI:0914”(association) | 0.350 |
| CDX1 | ZNF724 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (62): ZNF121 (Affinity Capture-MS), ZNF121 (Affinity Capture-MS), ZNF121 (Affinity Capture-MS), ZNF121 (Affinity Capture-MS), ZNF121 (Affinity Capture-MS), ZNF121 (Affinity Capture-MS), ZNF121 (Affinity Capture-MS), ZNF121 (Affinity Capture-MS), ZNF121 (Affinity Capture-MS), ZNF121 (Affinity Capture-MS), ZNF121 (Affinity Capture-MS), ZNF121 (Affinity Capture-MS), ZNF121 (Affinity Capture-MS), ZNF121 (Two-hybrid), ZNF121 (Two-hybrid)
ESM2 similar proteins: A6NP11, B4DXR9, O43361, O95780, P0CJ79, P0DKX0, P17021, P17024, P17035, P51508, P52740, P52741, P58317, Q02386, Q0VGE8, Q13106, Q13360, Q13398, Q5JVG2, Q5RBQ3, Q5RES8, Q5TYW1, Q68DI1, Q68EA5, Q6NX49, Q6P9A1, Q6P9A3, Q6PDB4, Q6ZN06, Q76KX8, Q7L945, Q7Z340, Q86T29, Q8BZW4, Q8IW36, Q8N823, Q8N8Z8, Q8NEP9, Q8TA94, Q8TC21
Diamond homologs: A0JPL0, A1L1L7, A2A761, A2VDP4, A3KN36, A6QLU5, A6QPT6, A7MBI1, A8MT65, B2RXC5, E9PYI1, E9Q8G5, O75290, O94892, O95780, P10076, P17014, P17023, P17025, P17030, P17032, P17098, P51523, P51814, P52736, P52742, P58317, Q02975, Q06730, Q06732, Q08DG8, Q0VCB0, Q13360, Q14584, Q14587, Q14590, Q147U1, Q16587, Q29RZ4, Q2M218
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 71 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| rRNA processing in the nucleus and cytosol | 5 | 16.8× | 7e-04 |
| rRNA processing | 5 | 15.2× | 7e-04 |
| Peptide chain elongation | 5 | 13.2× | 8e-04 |
| Viral mRNA Translation | 5 | 13.2× | 8e-04 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | 5 | 13.1× | 8e-04 |
| Selenocysteine synthesis | 5 | 12.5× | 8e-04 |
| Eukaryotic Translation Termination | 5 | 12.5× | 8e-04 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 5 | 12.3× | 8e-04 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| RNA processing | 5 | 16.1× | 2e-03 |
| cytoplasmic translation | 5 | 13.6× | 4e-03 |
| rRNA processing | 6 | 12.5× | 2e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
97 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 90 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1659 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:12133986:C:CC | acceptor_gain | 1.0000 |
| 19:12133990:A:T | acceptor_gain | 1.0000 |
| 19:12133991:G:GC | acceptor_gain | 1.0000 |
| 19:12135575:C:CT | acceptor_gain | 1.0000 |
| 19:12135575:C:T | acceptor_gain | 1.0000 |
| 19:12135763:TCTTA:T | donor_loss | 1.0000 |
| 19:12135764:CTTAC:C | donor_loss | 1.0000 |
| 19:12135765:TTAC:T | donor_loss | 1.0000 |
| 19:12135766:TA:T | donor_loss | 1.0000 |
| 19:12135767:A:AC | donor_gain | 1.0000 |
| 19:12135767:A:T | donor_loss | 1.0000 |
| 19:12135768:C:CA | donor_loss | 1.0000 |
| 19:12135768:C:CC | donor_gain | 1.0000 |
| 19:12135768:CCTA:C | donor_gain | 1.0000 |
| 19:12135907:C:CT | acceptor_gain | 1.0000 |
| 19:12135909:C:CT | acceptor_gain | 1.0000 |
| 19:12135910:A:C | acceptor_gain | 1.0000 |
| 19:12135912:A:C | acceptor_gain | 1.0000 |
| 19:12140175:CTCA:C | donor_loss | 1.0000 |
| 19:12140178:A:AC | donor_gain | 1.0000 |
| 19:12140178:AC:A | donor_gain | 1.0000 |
| 19:12140179:C:CT | donor_gain | 1.0000 |
| 19:12140179:CC:C | donor_gain | 1.0000 |
| 19:12140179:CCA:C | donor_gain | 1.0000 |
| 19:9568176:C:CC | acceptor_gain | 1.0000 |
| 19:9568187:C:CT | acceptor_gain | 1.0000 |
| 19:9568188:A:T | acceptor_gain | 1.0000 |
| 19:9568998:TCACC:T | donor_loss | 1.0000 |
| 19:9568999:CA:C | donor_loss | 1.0000 |
| 19:9569000:A:AC | donor_gain | 1.0000 |
AlphaMissense
2594 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:9566133:A:G | L327P | 0.996 |
| 19:9566150:A:C | F321L | 0.996 |
| 19:9566150:A:T | F321L | 0.996 |
| 19:9566152:A:G | F321L | 0.996 |
| 19:9566066:G:C | F349L | 0.995 |
| 19:9566066:G:T | F349L | 0.995 |
| 19:9566068:A:G | F349L | 0.995 |
| 19:9566234:G:C | F293L | 0.995 |
| 19:9566234:G:T | F293L | 0.995 |
| 19:9566236:A:G | F293L | 0.995 |
| 19:9566486:G:C | F209L | 0.995 |
| 19:9566486:G:T | F209L | 0.995 |
| 19:9566488:A:G | F209L | 0.995 |
| 19:9566570:G:C | F181L | 0.995 |
| 19:9566570:G:T | F181L | 0.995 |
| 19:9566572:A:G | F181L | 0.995 |
| 19:9566049:A:G | L355P | 0.994 |
| 19:9566123:A:C | H330Q | 0.994 |
| 19:9566123:A:T | H330Q | 0.994 |
| 19:9566301:A:G | L271P | 0.993 |
| 19:9566454:C:G | R220P | 0.993 |
| 19:9566622:C:G | R164P | 0.993 |
| 19:9566207:A:C | H302Q | 0.992 |
| 19:9566207:A:T | H302Q | 0.992 |
| 19:9566291:G:C | H274Q | 0.992 |
| 19:9566291:G:T | H274Q | 0.992 |
| 19:9566318:G:C | F265L | 0.992 |
| 19:9566318:G:T | F265L | 0.992 |
| 19:9566320:A:G | F265L | 0.992 |
| 19:9566459:A:C | H218Q | 0.992 |
dbSNP variants (sampled 300 via entrez): RS1000014409 (19:9584516 G>T), RS1000069908 (19:9569263 T>C), RS1000093531 (19:9582964 C>T), RS1000157393 (19:9560955 T>C), RS1000166167 (19:9574682 A>C), RS1000375271 (19:9579683 T>A,C), RS1000379335 (19:9585597 C>T), RS1000462802 (19:9562036 T>C), RS1000493983 (19:9562391 C>T), RS1000574318 (19:9575596 A>G), RS1000672639 (19:9568197 GAAAAA>G,GAAAA,GAAAAAA,GAAAAAAA), RS1000911584 (19:9575880 G>A), RS1001024836 (19:9570298 C>T), RS1001142697 (19:9564077 T>C), RS1001289753 (19:9571777 C>A)
Disease associations
OMIM: gene MIM:194628 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
31 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Estradiol | increases expression | 2 |
| Tobacco Smoke Pollution | increases expression | 2 |
| Aflatoxin B1 | increases methylation, increases expression | 2 |
| TAK-243 | increases sumoylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| trichostatin A | affects expression | 1 |
| sodium arsenite | decreases expression | 1 |
| cobaltous chloride | decreases expression | 1 |
| zinc chromate | increases abundance, increases expression | 1 |
| coumarin | decreases phosphorylation | 1 |
| cupric oxide | increases expression | 1 |
| chromium hexavalent ion | increases abundance, increases expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| abrine | increases expression | 1 |
| jinfukang | decreases expression | 1 |
| Resveratrol | increases expression, affects cotreatment | 1 |
| Temozolomide | increases expression | 1 |
| Leflunomide | increases expression | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Amiodarone | increases expression | 1 |
| Vehicle Emissions | decreases methylation | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Caffeine | increases phosphorylation | 1 |
| Dimethyl Sulfoxide | increases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Smoke | decreases expression | 1 |
| Urethane | increases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
| Copper Sulfate | increases expression | 1 |
Cellosaurus cell lines
4 cell lines: 3 embryonic stem cell, 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_A8F0 | SEES3-1V human ZNF121, clone1 | Embryonic stem cell | Male |
| CVCL_A8F1 | SEES3-1V human ZNF121, clone2 | Embryonic stem cell | Male |
| CVCL_A8F2 | SEES3-1V human ZNF121, clone3 | Embryonic stem cell | Male |
| CVCL_XW04 | HEK293 eGFP-ZNF121 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.